AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)
On Thursday, AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)’s shares inclined 9,423.81% to $4.00.
AEZS has 21.40% institutional ownership while its EPS ratio was -0.28. The company has 632.72 million shares outstanding while market capitalization of the company was $2.16 billion. Price to book ratio was 0.67. Stock volatility for the month was booked as 17.27% while for the week was recorded as 17.92%.
The mean estimate for the short term price target for AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) stands at $0.65 according to 3 Analysts. The higher price target estimate for the stock has been calculated at $1.75 while the lower price target estimate is at $0.10.
Analysts mean recommendation for the stock is 1.70. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company engaged in developing treatments in oncology, endocrinology and women’s health.
J C Penney Company Inc (NYSE:JCP)
J C Penney Company Inc (NYSE:JCP)’s shares dropped -0.33% to $7.66.
JCP has the market capitalization of $2.35 billion. The stock has P/B ratio of 1.41 while EPS was $-1.81. Institutional ownership of the company was 86.10% while 305.49 million shares were outstanding. Net profit margin of the Company was -4.50% while its gross profit margin was 35.80%. Share of the company moved below its SMA 50 with -17.00%. ROE ratio was -28.40% while ROI was -5.00%.
The mean estimate for the short term price target for J C Penney Company Inc (NYSE:JCP) stands at $10.05 according to 20 Analysts. The higher price target estimate for the stock has been calculated at $17.00 while the lower price target estimate is at $5.00.
Analysts mean recommendation for the stock is 3.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
J C. Penney Company, Inc. (JCPenney) is a holding company. The Company’s operating subsidiary is J. C. Penney Corporation, Inc. (JCP). The Company’s business consists of selling merchandise and services to consumers through its department stores and Website at jcpenney.com, which utilizes applications for desktop, mobile and tablet devices.
Compania de Minas Buenaventura SAA (ADR) (NYSE:BVN)
At the end of Thursday’s trade, Compania de Minas Buenaventura SAA (ADR) (NYSE:BVN)‘s shares dipped -2.10% to $4.67.
BVN Its past 5-day performance at -16.16%. So far in 2015, the company has a year-to-date performance of -51.15%. The stock, as of last close, traded 3.78% up from its 52 week low and was -62.67% below its 52 week high. Its latest closing price was -47.71% below the SMA200 while the distance from SMA 50 and SMA 20 was -28.62% and -23.70% respectively.
The mean estimate for the short term price target for Compania de Minas Buenaventura SAA (ADR) (NYSE:BVN) stands at $9.07 according to 11 Analysts. The higher price target estimate for the stock has been calculated at $16.00 while the lower price target estimate is at $6.50.
Analysts mean recommendation for the stock is 2.70. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Compania de Minas Buenaventura SAA (Buenaventura) is a Peru-based mining company engaged in the exploration, mining, smelting and commercialization of gold and silver, as well as other metals and minerals.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.